Compare SHEL & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHEL | ISRG |
|---|---|---|
| Founded | 1907 | 1995 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.6B | 202.9B |
| IPO Year | N/A | 2000 |
| Metric | SHEL | ISRG |
|---|---|---|
| Price | $70.68 | $587.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $81.19 | ★ $609.29 |
| AVG Volume (30 Days) | ★ 4.5M | 1.6M |
| Earning Date | 02-05-2026 | 01-21-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | N/A | ★ 21.56 |
| EPS | 2.42 | ★ 7.56 |
| Revenue | ★ $269,075,000,000.00 | $9,612,000,000.00 |
| Revenue This Year | N/A | $21.13 |
| Revenue Next Year | N/A | $14.95 |
| P/E Ratio | ★ $13.81 | $77.56 |
| Revenue Growth | N/A | ★ 22.18 |
| 52 Week Low | $58.55 | $425.00 |
| 52 Week High | $77.47 | $616.00 |
| Indicator | SHEL | ISRG |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 60.50 |
| Support Level | $68.63 | $555.40 |
| Resistance Level | $75.56 | $603.88 |
| Average True Range (ATR) | 0.97 | 9.78 |
| MACD | -0.21 | 1.02 |
| Stochastic Oscillator | 31.31 | 64.29 |
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.